FDA grants accelerated approval for Eisai’s new Alzheimer’s drug
The U.S. Food and Drug Administration (FDA) on Friday granted accelerated approval for the Alzheimer’s drug LEQEMBI (lecanemab-irmb). The drug is developed by two biotech […]
FDA grants accelerated approval for Eisai’s new Alzheimer’s drug Read More »











